Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

EDDIE THARA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1932436821
CMS profile
179209
Location
DOWNEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$5,785.69

208 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,396.77 204
Education $388.92 4

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $505.72 15
PFIZER INC. $439.23 17
Novartis Pharmaceuticals Corporation $418.19 19
ABBVIE INC. $276.77 14
Janssen Biotech, Inc. $274.49 10
Incyte Corporation $252.49 8
Daiichi Sankyo Inc. $249.40 9
Merck Sharp & Dohme LLC $236.62 9
Celgene Corporation $231.51 5
BeOne Medicines USA, Inc. $218.34 3
GlaxoSmithKline, LLC. $180.48 8
ARRAY BIOPHARMA INC $175.02 8
E.R. Squibb & Sons, L.L.C. $164.01 10
Astellas Pharma US Inc $162.46 4
Eisai Inc. $151.94 6
Takeda Pharmaceuticals U.S.A., Inc. $137.10 5
Caris MPI, Inc. $134.96 1
Exelixis Inc. $122.63 4
Alexion Pharmaceuticals, Inc. $107.97 4
GENZYME CORPORATION $106.49 4
JAZZ PHARMACEUTICALS INC. $94.20 3
SEAGEN INC. $92.99 1
SOBI, INC $90.27 3
Lilly USA, LLC $90.26 3
Gilead Sciences, Inc. $86.67 3
PUMA BIOTECHNOLOGY, INC. $75.86 3
Karyopharm Therapeutics Inc. $55.83 2
Bayer Healthcare Pharmaceuticals Inc. $55.75 2
PROGENICS PHARMACEUTICALS, INC. $50.75 2
Genentech USA, Inc. $49.92 2
Blueprint Medicines Corporation $44.77 2
RECORDATI_RARE_DISEASES_INC. $41.46 2
Regeneron Healthcare Solutions, Inc. $33.33 1
Adaptive Biotechnologies Corporation $31.52 1
BeiGene USA, Inc. $31.03 2
Boehringer Ingelheim Pharmaceuticals, Inc. $30.94 1
Sumitomo Pharma America, Inc. $29.34 1
TAIHO ONCOLOGY, INC. $28.94 1
PharmaEssentia USA Corporation $27.06 1
Ipsen Biopharmaceuticals, Inc $26.57 1
Genmab U.S., Inc. $25.47 1
SUN PHARMACEUTICAL INDUSTRIES INC. $24.83 1
KYOWA KIRIN, INC. $23.22 1
ADC THERAPEUTICS AMERICA, INC. $21.99 1
EMD Serono, Inc. $21.90 1
Rigel Pharmaceuticals, Inc. $19.23 1
Secura Bio, Inc. $19.04 1
SHORLA ONCOLOGY INC. $16.73 1

Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

EDDIE THARA

NPI 1932436821 · CMS profile ID 179209

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

DOWNEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932436821?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
EDDIE THARA, NPI 1932436821, CMS profile ID 179209. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932436821?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). EDDIE THARA, NPI 1932436821, CMS profile ID 179209. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932436821?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
EDDIE THARA, NPI 1932436821, CMS profile ID 179209, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 208 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1932436821?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

208 matching records · $5,785.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 208 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 208.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $31.0306/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200521131 CMS
Novartis Pharmaceuticals Corporation $2.4906/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200521133 CMS
PFIZER INC. $16.3406/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230142791 CMS
Janssen Biotech, Inc. $28.5306/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174590751 CMS
Karyopharm Therapeutics Inc. $27.4906/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246644505 CMS
BeOne Medicines USA, Inc. $33.5306/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202892536 CMS
Genentech USA, Inc. $25.3206/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211510180 CMS
AstraZeneca Pharmaceuticals LP $100.0006/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242511190 CMS
Merck Sharp & Dohme LLC $23.4906/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238370869 CMS
E.R. Squibb & Sons, L.L.C. $23.4006/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184842783 CMS
Merck Sharp & Dohme LLC $32.5506/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238367099 CMS
SOBI, INC $32.6006/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240285069 CMS
JAZZ PHARMACEUTICALS INC. $33.0706/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234319304 CMS
Takeda Pharmaceuticals U.S.A., Inc. $32.1006/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223928334 CMS
Eisai Inc. $20.4306/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244477428 CMS
Daiichi Sankyo Inc. $26.2305/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197099077 CMS
KYOWA KIRIN, INC. $23.2205/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222107738 CMS
Novartis Pharmaceuticals Corporation $27.8305/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200521153 CMS
Lilly USA, LLC $29.9305/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186584230 CMS
PFIZER INC. $28.3705/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229956032 CMS
SEAGEN INC. $92.9905/20/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1230097469 CMS
SOBI, INC $25.4405/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240285064 CMS
PFIZER INC. $28.7305/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230092903 CMS
AstraZeneca Pharmaceuticals LP $23.9505/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206420989 CMS
Novartis Pharmaceuticals Corporation $20.6205/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200521145 CMS
ABBVIE INC. $23.3605/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204509373 CMS
ARRAY BIOPHARMA INC $16.6805/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230080287 CMS
E.R. Squibb & Sons, L.L.C. $28.1905/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184842775 CMS
PROGENICS PHARMACEUTICALS, INC. $28.5305/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245241890 CMS
PUMA BIOTECHNOLOGY, INC. $21.6805/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251742802 CMS
Alexion Pharmaceuticals, Inc. $24.6805/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202957320 CMS
Exelixis Inc. $28.2305/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218793719 CMS
Novartis Pharmaceuticals Corporation $10.9905/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200521149 CMS
Rigel Pharmaceuticals, Inc. $19.2305/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247373127 CMS
ABBVIE INC. $1.8904/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204509366 CMS
ABBVIE INC. $18.7204/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204509369 CMS
PFIZER INC. $6.7804/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230080696 CMS
PFIZER INC. $15.8004/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229991959 CMS
Daiichi Sankyo Inc. $29.1104/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197098189 CMS
Janssen Biotech, Inc. $24.2404/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174590904 CMS
Merck Sharp & Dohme LLC $31.6104/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238367101 CMS
Merck Sharp & Dohme LLC $27.2904/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238052617 CMS
Eisai Inc. $29.6604/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244477426 CMS
GlaxoSmithKline, LLC. $24.4504/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191746768 CMS
GENZYME CORPORATION $28.8304/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233503829 CMS
Bayer Healthcare Pharmaceuticals Inc. $29.0004/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225845425 CMS
Blueprint Medicines Corporation $18.7804/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235818286 CMS
Merck Sharp & Dohme LLC $24.0004/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238235009 CMS
Janssen Biotech, Inc. $28.8104/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174590647 CMS
RECORDATI_RARE_DISEASES_INC. $17.4504/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181725123 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,707.88 176
PY2020 $3,709.82 175
PY2021 $4,058.05 179
PY2022 $4,563.24 180
PY2023 $5,598.11 233
PY2024 $7,130.50 274
PY2025 $5,785.69 208

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $118,733.33 3
PY2024 Principal investigator $20,789.80 3
PY2023 Principal investigator $27,346.43 6
PY2022 Principal investigator $2,966.15 2
PY2021 Principal investigator $89,997.82 25
PY2020 Principal investigator $358,743.35 59
PY2019 Principal investigator $2,362,968.58 114

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $444.34 12/31/2025 Non-covered Recipient Entity
Cancer and Blood Research Center
A Phase 2a Study with Safety Run-in to Evaluate the Safety, Tolerability, and Preliminary Efficacy of FF-10832 Monotherapy or in Combination with Pembrolizumab in Patients with Advanced Solid Tumors No dispute reported 06/30/2026 1232932535
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $88.99 09/30/2025 Non-covered Recipient Entity
The Oncology Institute Of Hope And Innovation
A Randomized, Double-Blind, Phase 3 Trial of Adagrasib plus Pembrolizumab plus Chemotherapy vs. Placebo plus Pembrolizumab plus Chemotherapy in Participants with Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-4) No dispute reported 06/30/2026 1235993079
Principal investigator 1 Merck Sharp & Dohme LLC $118,200.00 04/04/2025 Non-covered Recipient Entity
Cancer and Blood Research Center
A Phase 2a Study with Safety Run-in to Evaluate the Safety, Tolerability, and Preliminary Efficacy of FF-10832 Monotherapy or in Combination with Pembrolizumab in Patients with Advanced Solid Tumors No dispute reported 06/30/2026 1232932537